| Process for preparing l-amino acids -> Monitor Keywords |
|
|
  Process for preparing l-amino acidsUSPTO Application #: 20070122832Title: Process for preparing l-amino acids Abstract: The invention relates to isolated polynucleotides comprising a polynucleotide sequence chosen from the group consisting of a) polynucleotide which is identical to the extent of at least 70% to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2, b) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70% to the amino acid sequence of SEQ ID No. 2, c) polynucleotide which is complementary to the polynucleotides of a) or b), and d) polynucleotide comprising at least 15 successive nucleotides of the polynucleotide sequence of a), b) or c), and a process for the fermentative preparation of L-amino acids using coryneform bacteria in which at least the citA gene is present in attenuated form, and the use of polynucleotides which comprise the sequences according to the invention as hybridization probes. (end of abstract) Agent: Pillsbury Winthrop Shaw Pittman, LLP - Mclean, VA, US Inventors: Bettina Mockel, Mike Farwick, Thomas Hermann, Achim Marx, Walter Pfefferle USPTO Applicaton #: 20070122832 - Class: 435006000 (USPTO) Related Patent Categories: Chemistry: Molecular Biology And Microbiology, Measuring Or Testing Process Involving Enzymes Or Micro-organisms; Composition Or Test Strip Therefore; Processes Of Forming Such Composition Or Test Strip, Involving Nucleic Acid The Patent Description & Claims data below is from USPTO Patent Application 20070122832. Brief Patent Description - Full Patent Description - Patent Application Claims
[0001] The invention provides nucleotide sequences from coryneform bacteria which code for the citA gene and a process for the fermentative preparation of amino acids, in particular L-lysine, by attenuation of the citA gene. The citA gene codes for the sensor kinase CitA of a two-component system. PRIOR ART [0002] L-Amino acids, in particular L-lysine, are used in human medicine and in the pharmaceuticals industry, in the foodstuffs industry and very particularly in animal nutrition. [0003] It is known that amino acids are prepared by fermentation from strains of coryneform bacteria, in particular Corynebacterium glutamicum. Because of their great importance, work is constantly being undertaken to improve the preparation processes. Improvements to the process can relate to fermentation measures, such as, for example, stirring and supply of oxygen, or the composition of the nutrient media, such as, for example, the sugar concentration during the fermentation, or the working up to the product form by, for example, ion exchange chromatography, or the intrinsic output properties of the microorganism itself. [0004] Methods of mutagenesis, selection and mutant selection are used to improve the output properties of these microorganisms. Strains which are resistant to antimetabolites or are auxotrophic for metabolites of regulatory importance and which produce amino acids are obtained in this manner. [0005] Methods of the recombinant DNA technique have also been employed for some years for improving the strain of Corynebacterium strains which produce L-amino acids. OBJECT OF THE INVENTION [0006] The inventors had the object of providing new measures for improved fermentative preparation of amino acids, in particular L-lysine. DESCRIPTION OF THE INVENTION [0007] If L-lysine or lysine are mentioned in the following, this also means the salts, such as e.g. lysine monohydrochloride or lysine sulfate. [0008] The invention provides an isolated polynucleotide from coryneform bacteria, comprising a polynucleotide sequence which codes for the citA gene chosen from the group consisting of [0009] a) polynucleotide which is identical to the extent of at least 70% to a polynucleotide which codes for a polypeptide which comprises the amino acid sequence of SEQ ID No. 2, [0010] b) polynucleotide which codes for a polypeptide which comprises an amino acid sequence which is identical to the extent of at least 70% to the amino acid sequence of SEQ ID No. 2, [0011] c) polynucleotide which is complementary to the polynucleotides of a) or b), and [0012] d) polynucleotide comprising at least 15 successive nucleotides of the polynucleotide sequence of a), b) or c), the polypeptide preferably having the activity of sensor kinase CitA. [0013] The invention also provides the abovementioned polynucleotide, this preferably being a DNA which is capable of replication, comprising: [0014] (i) the nucleotide sequence shown in SEQ ID No.1 or [0015] (ii) at least one sequence which corresponds to sequence (i) within the range of the degeneration of the genetic code, or [0016] (iii) at least one sequence which hybridizes with the sequences complementary to sequences (i) or (ii), and optionally [0017] (iv) sense mutations of neutral function in (i). [0018] The invention also provides: [0019] a polynucleotide, in particular DNA, which is capable of replication and comprises the nucleotide sequence as shown in SEQ ID No.1; [0020] a polynucleotide which codes for a polypeptide which comprises the amino acid sequence as shown in SEQ ID No. 2; [0021] a vector containing parts of the polynucleotide according to the invention, but at least 15 successive nucleotides of the sequence claimed [0022] and coryneform bacteria in which the citA gene is attenuated, in particular by an insertion or deletion. [0023] The invention also provides polynucleotides which substantially comprise a polynucleotide sequence, which are obtainable by screening by means of hybridization of a corresponding gene library of a coryneform bacterium, which comprises the complete gene or parts thereof, with a probe which comprises the sequence of the polynucleotide according to the invention or a fragment thereof, and isolation of the polynucleotide sequence mentioned. [0024] Polynucleotides comprising the sequences according to the invention are suitable as hybridization probes for RNA, cDNA and DNA, in order to isolate, in the full length, nucleic acids or polynucleotides or genes which code for CitA protein or to isolate those nucleic acids or polynucleotides or genes which have a high similarity with the sequence of the citA gene. [0025] Polynucleotides comprising the sequences according to the invention are furthermore suitable as primers with the aid of which DNA of genes which code for the CitA protein can be prepared by the polymerase chain reaction (PCR). [0026] Such oligonucleotides which serve as probes or primers comprise at least 30, preferably at least 20, very particularly preferably at least 15 successive nucleotides. Oligonucleotides which have a length of at least 40 or 50 nucleotides are also suitable. [0027] "Isolated" means separated out of its natural environment. [0028] "Polynucleotide" in general relates to polyribonucleotides and polydeoxyribonucleotides, it being possible for these to be non-modified RNA or DNA or modified RNA or DNA. [0029] The polynucleotides according to the invention include a polynucleotide according to SEQ ID No. 1 or a fragment prepared therefrom and also those which are at least 70%, preferably at least 80% and in particular at least 90% to 95% identical to the polynucleotide according to SEQ ID No. 1 or a fragment prepared therefrom. [0030] "Polypeptides" are understood as meaning peptides or proteins which comprise two or more amino acids bonded via peptide bonds. [0031] The polypeptides according to the invention include a polypeptide according to SEQ ID No. 2, in particular those with the biological activity of the CitA protein and also those which are at least 70%, preferably at least 80% and in particular at least 90% to 95% identical to the polypeptide according to SEQ ID No. 2 and have the activity mentioned. [0032] The invention moreover relates to a process for the fermentative preparation of amino acids, in particular L-lysine, using coryneform bacteria which in particular already produce amino acids and in which the nucleotide sequences which code for the citA gene are attenuated, in particular eliminated or expressed at a low level. [0033] The term "attenuation" in this connection describes the reduction or elimination of the intracellular activity of one or more enzymes (proteins) in a microorganism which are coded by the corresponding DNA, for example by using a weak promoter or using a gene or allele which codes for a corresponding enzyme with a low activity or inactivates the corresponding gene or enzyme (protein), and optionally combining these measures. Continue reading... Full patent description for Process for preparing l-amino acids Brief Patent Description - Full Patent Description - Patent Application Claims Click on the above for other options relating to this Process for preparing l-amino acids patent application. ###  How KEYWORD MONITOR works... a FREE service from FreshPatents1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored. 3. Each week you receive an email with patent applications related to your keywords. Start now! - Receive info on patent apps like Process for preparing l-amino acids or other areas of interest. ### Previous Patent Application: Predicting graft rejection Next Patent Application: Prohibitin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance Industry Class: Chemistry: molecular biology and microbiology ### FreshPatents.com Support Thank you for viewing the Process for preparing l-amino acids patent info. IP-related news and info Results in 1.68926 seconds Other interesting Feshpatents.com categories: Daimler Chrysler , DirecTV , Exxonmobil Chemical Company , Goodyear , Intel , Kyocera Wireless , |
||
